Skip to main content
All lobbying firms

TEVA PHARMACEUTICALS USA, INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported
1 Clients represented
7 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $4,310,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. 1 filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the registrant's LDA id (76695), not by name.

 Clients 1
 Reported by year 2 years
  • 2026 $1,790,000 3 filings
  • 2025 $2,520,000 4 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 9
  • Centers For Medicare and Medicaid Services (CMS) 7
  • Commerce, Dept of (DOC) 7
  • Executive Office of the President (EOP) 7
  • Food & Drug Administration (FDA) 7
  • Health & Human Services, Dept of (HHS) 7
  • Homeland Security, Dept of (DHS) 7
  • HOUSE OF REPRESENTATIVES 7
  • SENATE 7
  • U.S. Trade Representative (USTR) 7
 Recent filings 8 total
Q3 report
TEVA PHARMACEUTICALS USA INC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $310,000 expenses · posted Oct 16, 2026
View → Q2 report
TEVA PHARMACEUTICALS USA INC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $380,000 expenses · posted Jul 17, 2026
View → Q1 report
TEVA PHARMACEUTICALS USA INC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $1,100,000 expenses · posted Apr 20, 2026
View → Q4 report
TEVA PHARMACEUTICALS USA INC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $360,000 expenses · posted Jan 14, 2026
View → Q3 report
TEVA PHARMACEUTICALS USA INC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $460,000 expenses · posted Oct 17, 2025
View → Q2 amendment
TEVA PHARMACEUTICALS USA INC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $1,390,000 expenses · posted Sep 4, 2025
View → Q2 report
TEVA PHARMACEUTICALS USA INC Amended
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $1,390,000 expenses · posted Jul 17, 2025
View → Q1 report
TEVA PHARMACEUTICALS USA INC
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $310,000 expenses · posted Apr 18, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem